11 reports

  • DRUG DEVELOPMENT THROUGH COLLABORATION

Acceleron Pharma ##. ##.

  • Blood Disease
  • Pathology
  • Pharmaceutical
  • Therapy
  • FibroGen, Inc.

MOBILE Mobile advertising has primarily driven social media ad spend by pharmaceutical & healthcare brands, accounting for ##%, in 2015.

  • Advertising
  • Computer
  • Pharmaceutical
  • Web 2.0
  • Tencent Holdings Ltd

FIGURE ##: CHINA RETAIL BRANDS' ONLINE ADVERTISING SPEND - SPLIT BY MOBILE AND DESKTOP (US$ MILLION), 2015 VS. 2020 ##. ## Pharmaceutical & Healthcare Online Ad Spend Being among the few countries that allow direct to consumer marketing of pharmaceutical products, digital ad

  • Advertising
  • Computer
  • Online Advertising
  • Pharmaceutical
  • Tencent Holdings Ltd

MOBILE Mobile advertising has primarily driven social media ad spend by pharmaceutical & healthcare brands, accounting for ##%, in 2014.

  • Advertising
  • Marketing
  • Pharmaceutical
  • Web 2.0
  • Tencent Holdings Ltd

FIGURE ##: CHINA PHARMACEUTICAL & HEALTHCARE BRANDS' ONLINE ADVERTISING SPEND (US$ MILLION), 2010-2019 ##. ##. ## SNAPSHOT, 2010-2019 FIGURE ##: CHINA PHARMACEUTICAL & HEALTHCARE BRANDS' ONLINE ADVERTISING SPEND - BREAKDOWN BY MARKETING OBJECTIVE (%), 2014VS. 2019 Bran

  • Advertising
  • Computer
  • Online Advertising
  • Pharmaceutical
  • Tencent Holdings Ltd
  • LARGE MOLECULES COMPETITIVE LANDSCAPE
  • SMALL MOLECULES

Astellas Pharma Inc.

  • Pharmaceutical
  • Renal Disease
  • Therapy
  • Type 2 Diabetes
  • FibroGen, Inc.
  • FIBROGEN INC, PHARMACEUTICALS & HEALTHCARE DEALS BY TYPE, 2011 TO YTD 2017
  • FIBROGEN INC, PHARMACEUTICALS & HEALTHCARE, DEALS BY REGION, 2011 TO YTD 2017
  • Pharmaceutical
  • Therapy
  • China
  • United States
  • FibroGen, Inc.
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2016
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2016 (CONTD..1)

Procter & Gamble Pharmaceuticals, Inc.

  • Blood Disease
  • Pharmaceutical
  • United States
  • Product Initiative
  • FibroGen, Inc.
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2015
  • randomized, open-label, active-controlled clinical trial of patients with ESRD undergoing hemodialysis three times a week.

Acceleron Pharma, Inc.

  • Blood Disease
  • Pharmaceutical
  • United States
  • Product Initiative
  • FibroGen, Inc.

FibroGen Inc operates within the Pharmaceutical preparations sector.

  • Pharmaceutical
  • United States
  • Company Financials
  • FibroGen, Inc.
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2015
  • FEATURED NEWS & PRESS RELEASES

Acceleron Pharma, Inc.

  • Blood Disease
  • Pharmaceutical
  • Research And Development
  • United States
  • FibroGen, Inc.